Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Life Sciences - October, 2005
49 articles
- In Setback for Glaxo, U.K. Invalidates Paxil Patent
- Supreme Court Rebuffs Solicitor General, Takes LabCorp Case
- Lawsuits Make Company Worth More Dead Than Alive
- Patent Fight Over Microscope Gear Trudges On
- Acacia Targets Heavy Industry With New Patent
- Bausch And Lomb Audits Brazilian Branch Amid Fraud Allegations
- Connetics Files Suit Over Agis ANDA
- Sun Pharma Takes Unique Road To Victory Vs. J&J
- CAT And Abbott Settle Humira Royalties Dispute
- Eye Care Rivals Face Threat From IP Holding Company
- Court Blasts FDA Over Pravachol Generic Launch
- Market Exclusivity "Give-Away" Gone In Bioterror Bill
- Texas Challenges California As IP Litigation Hotbed
- Shire Sues Barr, Impax Again Over Adderall Patents
- Stanford Sues Roche Over HIV Monitoring Technology
- Complying With License, MedImmune Loses Case
- Biovail Files 2nd Suit To Protect Blood Pressure Drug
- Barrier Therapeutics Misled Over Clinical Studies, Suit Says
- Roche Mulls Sub-Licensing Bird Flu Drug
- Bristol-Meyers Squibb In Class Action Over $2B Fraud
- Investors Sue Andrx Amid FDA Skirmish
- Wyeth, Teva Strike Deal On Antidepressant Generic
- J&J Suffers Headache Over Migraine Generic
- Bioterrorism Defense Bill Could Change Patent Law
- Ranbaxy, AstraZeneca Battle Looms Over Ulcer Drug
- Supreme Court Lets Merck Loss In Fosamax Case Stand
- J&J Challenged Over Schizophrenia Drug Patent
- SEC Sues Wood Partners Over Investment Decision
- Indian Drug Company To Copy Roche Flu Drug
- J&J Loses Dutch Stent Trial Against Boston Scientific
- Former Hedge Fund Exec Pleads Guilty In Pharma Stock Scandal
- Hatch Eyes FDA For Move On Generic Biologics
- U.K. Upholds One Lipitor Patent, Invalidates Another
- Biotech Companies Clash Over HPV, HCV Patents
- Supreme Court Lets Stand Landmark Drug Ruling
- Hedge Fund Won't Return Investors' Calls, SEC Probing
- Jilted Ranbaxy Sues Barr, Teva Over Allegra Generic
- FDA Tip Sparks SEC Biopure Investigation
- U.K. To Decide On Lipitor Patent Wednesday
- Alphapharm Concedes To Forest Labs In Antidepressant Battle
- Invitrogen V. Stratagene Remanded Again
- Novo Nordisk Misled USPTO, Federal Circuit Rules
- In Unusal Twist, Defendant Appeals Dismissal Of Biotech Patent Lawsuit
- Medtronic Awarded $51 Million in BrainLab Suit
- Acacia In New Deal With AMD Over Bar-Code Patents
- Federal Circuit Overturns Injunction Against Medtronic
- Patent Suit Dropped After Supreme Court "Safe Harbor" Ruling
- After 13 Years, Medical Device Makers Pen $75M Settlement
- Smith & Nephew, ArthroCare Settle Patent Suit Over Surgical Devices